Kalofonos Isabel bought CRNX
January 5, 2026 · Form 4 insider transaction
Kalofonos Isabel bought 2,500 shares of Crinetics Pharmaceuticals Inc at $40.59 per share, a transaction worth $101.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,500
Price
$40.59
Total value
$101.5K
InsiderKalofonos Isabel
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after3,334
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 834 shares acquired under the Issuer's Employee Stock Purchase Plan.